These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1808859)

  • 21. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
    Baronti A; Lelli M; Manini G; Verdiani P
    Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
    Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
    Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
    Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
    Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients.
    Turner MO; Gafni A; Swan D; FitzGerald JM
    Arch Intern Med; 1996 Oct; 156(18):2113-8. PubMed ID: 8862104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 28. [Asthma and inhalation therapy: the points of view of the patient and the therapist].
    Huchon G
    Allerg Immunol (Paris); 1993 Oct; 25(8):354-8. PubMed ID: 7903537
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary rehabilitation for COPD patients.
    Make BJ; Paine R
    Hosp Pract (Off Ed); 1987 Jan; 22(1A):26-7, 31-4. PubMed ID: 3100551
    [No Abstract]   [Full Text] [Related]  

  • 30. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
    Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
    Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
    [No Abstract]   [Full Text] [Related]  

  • 31. [Response to inhaled bronchodilators in chronic airway obstruction].
    Holten K
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications for domiciliary nebulised bronchodilators and apparatus for administration.
    Wilson RS
    Physiotherapy; 1979 Nov; 65(11):346-7. PubMed ID: 545411
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of children's metered-dose inhaler technique for asthma medications.
    Burkhart PV; Rayens MK; Bowman RK
    Nurs Clin North Am; 2005 Mar; 40(1):167-82. PubMed ID: 15733954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.
    Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E
    Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
    Krecklow B
    Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhalable drugs for systemic therapy.
    Corkery K
    Respir Care; 2000 Jul; 45(7):831-5. PubMed ID: 10926380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
    Singer AJ; Emerman C; Char DM; Heywood JT; Kirk JD; Hollander JE; Summers R; Lee CC; Wynne J; Kellerman L; Peacock WF
    Ann Emerg Med; 2008 Jan; 51(1):25-34. PubMed ID: 17949853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Skill in the handling of aerosols by health care personnel].
    Felez MA; González Clemente JM; Cardona Q; Montserrat JM; Picado C
    Rev Clin Esp; 1991 Mar; 188(4):185-7. PubMed ID: 1784742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pressurized aerosol inhaler technique: how important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs?
    Lawford P; McKenzie D
    Br J Dis Chest; 1983 Jul; 77(3):276-81. PubMed ID: 6615704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.